Human TNBC Cells 48h Treatment with OTSSP167 MELK Inhibitor vs. DMSO Control
收藏官方服务：
资源简介：
Human TNBC Cells 48h Treatment with OTSSP167 MELK Inhibitor vs. DMSO Control
应用场景：
创建时间：
2017-05-01
相关数据集
Table_1_Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression.xlsx
Resveratrol (RSV) is known to possess anticancer properties in many types of cancers like breast cancer, in which POLD1 may serve as a potential target. However, the anticancer mechanism of RSV on tri
NIAID Data Ecosystem70
Cytochalasin D as a potential MAPK family inhibitor for treating triple-negative breast cancer
Cytochalasin D, a potent fungal metabolite, has garnered considerable attention due to its diverse biological activities and potential pharmacological applications. Renowned for its ability to disrupt
Taylor & Francis Group2025-02-27 更新50
Small molecule-mediated ERO1A inhibition in restraining aggressive breast cancer
Cancer cells adapt to harsh environmental conditions by inducing the Unfolded Protein Response (UPR), of which ERO1A is one of the mediators. ERO1A aids protein folding by acting as a protein disulfid
NIAID Data Ecosystem40
Metadata record for the manuscript: Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: A phase II and biomarker study
Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer:
NIAID Data Ecosystem60
A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy
Patients with triple-negative breast cancer (TNBC) often have a poor prognosis largely due to lack of effective targeted therapy. Using a library of seleno-purines coupled to a high-throughput biochem
NIAID Data Ecosystem50
